Fuse Medical Stock

Fuse Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Fuse Medical (FZMD) as of Aug 4, 2026 is 383,783.00 USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 721,412.00 USD — a change of -46.80% (lower).

EBITDA

383,783.00USD

YoY

-46.80%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Fuse Medical is 2026 383,783.00 USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Fuse Medical was 2025 721,412.00 USD. It decreases by -46.80% lower compared to the previous year.
Access this data via the Eulerpool API

Fuse Medical Stock analysis

What does Fuse Medical do? Fuse Medical Inc. is a US-based company specializing in the distribution of orthopedic implants and blood circulation products. Founded in 2014, the company is headquartered in Richardson, Texas. The business model of Fuse Medical is based on the distribution of orthopedic implants, consumables, and instruments to medical practices, hospitals, and surgical facilities. The company works closely with leading manufacturers to offer its customers a wide range of high-quality products. Fuse Medical's product range includes primary and revision implants for various areas such as hips, knees, shoulders, and the spine. In addition, Fuse Medical also offers a wide range of instruments to meet the needs of its customers. These products are supplied by a variety of manufacturers from around the world, allowing Fuse Medical to meet the needs of its customers. In recent years, Fuse Medical has also focused on the distribution of blood circulation products, including non-invasive devices to improve circulation and devices for the treatment of wound healing disorders. These products contribute to improving the quality of life for patients and are an important part of the company's business model. Fuse Medical has experienced good development in recent years and has successfully established itself in the market for orthopedic implants. The company is constantly working to expand its product range and support its customers around the world. This includes continuous training and education of staff to continuously improve the quality of products and customer service. In addition to the distribution of implants and medical devices, Fuse Medical also offers a wide range of services to its customers. This includes fast delivery directly to facilities, inventory management, support for storage, distribution, and maintenance of medical equipment, as well as training for medical personnel. Fuse Medical aims to offer high-quality products and services that meet customer needs and contribute to improving patient care. The company is committed to continuously developing new products through innovation and research that meet the needs of its customers and the latest industry requirements. In summary, Fuse Medical is a successful company specializing in the distribution of orthopedic implants and blood circulation products. The company offers a wide range of products and services and works closely with its customers and manufacturers to ensure the highest quality. Fuse Medical will continue to strive to provide its customers with the best products and services and establish itself as a leading company in the industry. Fuse Medical specializes in the distribution of orthopedic implants and blood circulation products. Fuse Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fuse Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Fuse Medical is 383,783.00 USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Fuse Medical changed from 721,412.00 USD to 383,783.00 USD, representing a -46.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Fuse Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Fuse Medical historically and in real time.

Access this data via the Eulerpool API

Income Statement — Fuse Medical

All Key Metrics — Fuse Medical